Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Pretreatment behavior and subsequent medication effects in childhood absence epilepsy.

Shinnar RC, Shinnar S, Cnaan A, Clark P, Dlugos D, Hirtz DG, Hu F, Liu C, Masur D, Weiss EF, Glauser TA; Childhood Absence Epilepsy Study Group.

Neurology. 2017 Oct 17;89(16):1698-1706. doi: 10.1212/WNL.0000000000004514. Epub 2017 Sep 15.

2.

Second monotherapy in childhood absence epilepsy.

Cnaan A, Shinnar S, Arya R, Adamson PC, Clark PO, Dlugos D, Hirtz DG, Masur D, Glauser TA; Childhood Absence Epilepsy Study Group.

Neurology. 2017 Jan 10;88(2):182-190. doi: 10.1212/WNL.0000000000003480. Epub 2016 Dec 16.

3.

Cognitive functioning one month and one year following febrile status epilepticus.

Weiss EF, Masur D, Shinnar S, Hesdorffer DC, Hinton VJ, Bonner M, Rinaldi J, Van de Water V, Culbert J, Shinnar RC, Seinfeld S, Gallentine W, Nordli DR Jr, Frank LM, Epstein L, Moshé SL, Sun S; FEBSTAT study team.

Epilepsy Behav. 2016 Nov;64(Pt A):283-288. doi: 10.1016/j.yebeh.2016.09.013. Epub 2016 Oct 26.

4.

Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trial.

Shinnar S, Cnaan A, Hu F, Clark P, Dlugos D, Hirtz DG, Masur D, Mizrahi EM, Moshé SL, Glauser TA; Childhood Absence Epilepsy Study Group.

Neurology. 2015 Sep 29;85(13):1108-14. doi: 10.1212/WNL.0000000000001971. Epub 2015 Aug 26.

5.

Orbitofrontal cortex dysfunction in psychogenic non-epileptic seizures. A proposal for a two-factor model.

Pillai JA, Haut SR, Masur D.

Med Hypotheses. 2015 Apr;84(4):363-9. doi: 10.1016/j.mehy.2015.01.034. Epub 2015 Jan 28.

PMID:
25683388
6.

Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study.

Lewis DV, Shinnar S, Hesdorffer DC, Bagiella E, Bello JA, Chan S, Xu Y, MacFall J, Gomes WA, Moshé SL, Mathern GW, Pellock JM, Nordli DR Jr, Frank LM, Provenzale J, Shinnar RC, Epstein LG, Masur D, Litherland C, Sun S; FEBSTAT Study Team.

Ann Neurol. 2014 Feb;75(2):178-85. doi: 10.1002/ana.24081. Epub 2014 Mar 1.

7.

Influence of anxiety on memory performance in temporal lobe epilepsy.

Brown FC, Westerveld M, Langfitt JT, Hamberger M, Hamid H, Shinnar S, Sperling MR, Devinsky O, Barr W, Tracy J, Masur D, Bazil CW, Spencer SS.

Epilepsy Behav. 2014 Feb;31:19-24. doi: 10.1016/j.yebeh.2013.10.009. Epub 2013 Nov 26.

8.

Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy.

Masur D, Shinnar S, Cnaan A, Shinnar RC, Clark P, Wang J, Weiss EF, Hirtz DG, Glauser TA; Childhood Absence Epilepsy Study Group.

Neurology. 2013 Oct 29;81(18):1572-80. doi: 10.1212/WNL.0b013e3182a9f3ca. Epub 2013 Oct 2.

9.

Risk factors for febrile status epilepticus: a case-control study.

Hesdorffer DC, Shinnar S, Lewis DV, Nordli DR Jr, Pellock JM, Moshé SL, Shinnar RC, Litherland C, Bagiella E, Frank LM, Bello JA, Chan S, Masur D, Macfall J, Sun S; Consequences of Prolonged Febrile Seizures in Childhood (FEBSTAT) Study Team.

J Pediatr. 2013 Oct;163(4):1147-51.e1. doi: 10.1016/j.jpeds.2013.05.038. Epub 2013 Jul 1.

10.

Pretreatment EEG in childhood absence epilepsy: associations with attention and treatment outcome.

Dlugos D, Shinnar S, Cnaan A, Hu F, Moshé S, Mizrahi E, Masur D, Sogawa Y, Le Pichon JB, Levine C, Hirtz D, Clark P, Adamson PC, Glauser T; Childhood Absence Epilepsy Study Team.

Neurology. 2013 Jul 9;81(2):150-6. doi: 10.1212/WNL.0b013e31829a3373. Epub 2013 May 29.

11.

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.

Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, Clark PO, Adamson PC; Childhood Absence Epilepsy Study Team.

Epilepsia. 2013 Jan;54(1):141-55. doi: 10.1111/epi.12028. Epub 2012 Nov 21.

12.

Design and phenomenology of the FEBSTAT study.

Hesdorffer DC, Shinnar S, Lewis DV, Moshé SL, Nordli DR Jr, Pellock JM, MacFall J, Shinnar RC, Masur D, Frank LM, Epstein LG, Litherland C, Seinfeld S, Bello JA, Chan S, Bagiella E, Sun S; FEBSTAT study team.

Epilepsia. 2012 Sep;53(9):1471-80. doi: 10.1111/j.1528-1167.2012.03567.x. Epub 2012 Jun 28.

13.

Cognitive outcomes in children who present with a first unprovoked seizure.

Sogawa Y, Masur D, O'Dell C, Moshe SL, Shinnar S.

Epilepsia. 2010 Dec;51(12):2432-9. doi: 10.1111/j.1528-1167.2010.02724.x. Epub 2010 Sep 24.

14.

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.

Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, Clark PO, Capparelli EV, Adamson PC; Childhood Absence Epilepsy Study Group.

N Engl J Med. 2010 Mar 4;362(9):790-9. doi: 10.1056/NEJMoa0902014.

15.

Network "Rodent-borne pathogens" in Germany: longitudinal studies on the geographical distribution and prevalence of hantavirus infections.

Ulrich RG, Schmidt-Chanasit J, Schlegel M, Jacob J, Pelz HJ, Mertens M, Wenk M, Büchner T, Masur D, Sevke K, Groschup MH, Gerstengarbe FW, Pfeffer M, Oehme R, Wegener W, Bemmann M, Ohlmeyer L, Wolf R, Zoller H, Koch J, Brockmann S, Heckel G, Essbauer SS.

Parasitol Res. 2008 Dec;103 Suppl 1:S121-9. doi: 10.1007/s00436-008-1054-9. Epub 2008 Nov 23. Review.

PMID:
19030894
16.

Worsening of quality of life after epilepsy surgery: effect of seizures and memory decline.

Langfitt JT, Westerveld M, Hamberger MJ, Walczak TS, Cicchetti DV, Berg AT, Vickrey BG, Barr WB, Sperling MR, Masur D, Spencer SS.

Neurology. 2007 Jun 5;68(23):1988-94.

PMID:
17548548
17.

The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians.

Crystal HA, Dickson D, Davies P, Masur D, Grober E, Lipton RB.

Arch Neurol. 2000 May;57(5):713-9.

PMID:
10815138
18.

Psychiatric disorders in patients with fibromyalgia. A multicenter investigation.

Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, Kuck J, Leslie V, Masur D, Wagner M, Waid R, Zisook S.

Psychosomatics. 1999 Jan-Feb;40(1):57-63.

PMID:
9989122
19.

Pain, fatigue, and sleep in eosinophilia-myalgia syndrome: relationship to neuropsychological performance.

Pollina DA, Kaufman LD, Masur DM, Krupp LB.

J Neuropsychiatry Clin Neurosci. 1998 Summer;10(3):338-42.

PMID:
9706542
20.

The effect of dementia risk factors on comparative and diagnostic selective reminding norms.

Sliwinski M, Buschke H, Stewart WF, Masur D, Lipton RB.

J Int Neuropsychol Soc. 1997 Jul;3(4):317-26.

PMID:
9260441
21.

The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.

Geisler MW, Sliwinski M, Coyle PK, Masur DM, Doscher C, Krupp LB.

Arch Neurol. 1996 Feb;53(2):185-8.

PMID:
8639070
22.

Associations of status and change measures of neuropsychological function with pathologic changes in elderly, originally nondemented subjects.

Crystal HA, Dickson D, Sliwinski M, Masur D, Blau A, Lipton RB.

Arch Neurol. 1996 Jan;53(1):82-7.

PMID:
8599564
23.

Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons.

Masur DM, Sliwinski M, Lipton RB, Blau AD, Crystal HA.

Neurology. 1994 Aug;44(8):1427-32.

PMID:
8058143
24.

Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis.

Krupp LB, Sliwinski M, Masur DM, Friedberg F, Coyle PK.

Arch Neurol. 1994 Jul;51(7):705-10.

PMID:
8018045
25.

Neurocognitive dysfunction in the eosinophilia-myalgia syndrome.

Krupp LB, Masur DM, Kaufman LD.

Neurology. 1993 May;43(5):931-6.

PMID:
8492948
26.

Developmental disorder or schizophrenia?

Virtue C, Iqbal N, Masur D, Schwartz B.

Am J Psychiatry. 1993 Mar;150(3):521. No abstract available.

PMID:
7679556
27.

Fluent aphasia in children: definition and natural history.

Klein SK, Masur D, Farber K, Shinnar S, Rapin I.

J Child Neurol. 1992 Jan;7(1):50-9.

PMID:
1372626
28.

Identification of normal and pathological aging in prospectively studied nondemented elderly humans.

Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson MK.

Neurobiol Aging. 1992 Jan-Feb;13(1):179-89.

PMID:
1311804
29.

Cognitive functioning in late Lyme borreliosis.

Krupp LB, Masur D, Schwartz J, Coyle PK, Langenbach LJ, Fernquist SK, Jandorf L, Halperin JJ.

Arch Neurol. 1991 Nov;48(11):1125-9.

PMID:
1953395
30.

Dementia. Age-dependent incidence, prevalence, and mortality in the old old.

Aronson MK, Ooi WL, Geva DL, Masur D, Blau A, Frishman W.

Arch Intern Med. 1991 May;151(5):989-92.

PMID:
2025148
31.

Predicting development of dementia in the elderly with the Selective Reminding Test.

Masur DM, Fuld PA, Blau AD, Crystal H, Aronson MK.

J Clin Exp Neuropsychol. 1990 Aug;12(4):529-38.

PMID:
2211975
32.

Object-memory evaluation for prospective detection of dementia in normal functioning elderly: predictive and normative data.

Fuld PA, Masur DM, Blau AD, Crystal H, Aronson MK.

J Clin Exp Neuropsychol. 1990 Aug;12(4):520-8.

PMID:
2211974
33.

Women, myocardial infarction, and dementia in the very old.

Aronson MK, Ooi WL, Morgenstern H, Hafner A, Masur D, Crystal H, Frishman WH, Fisher D, Katzman R.

Neurology. 1990 Jul;40(7):1102-6.

PMID:
2356012
34.

Preservation of musical memory in Alzheimer's disease.

Crystal HA, Grober E, Masur D.

J Neurol Neurosurg Psychiatry. 1989 Dec;52(12):1415-6.

35.

Distinguishing normal and demented elderly with the selective reminding test.

Masur DM, Fuld PA, Blau AD, Thal LJ, Levin HS, Aronson MK.

J Clin Exp Neuropsychol. 1989 Oct;11(5):615-30.

PMID:
2808653
36.

Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease.

Thal LJ, Masur DM, Blau AD, Fuld PA, Klauber MR.

J Am Geriatr Soc. 1989 Jan;37(1):42-8. Review.

PMID:
2642499
37.

Neuropsychological characteristics of subjects with and without neocortical Alz-50 immunoreactivity.

Crystal H, Davies P, Dickson D, Scicutella A, Blau A, Masur D.

Prog Clin Biol Res. 1989;317:165-73.

PMID:
2602414
38.

Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease.

Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu J, Kawas C, Aronson M, Wolfson L.

Neurology. 1988 Nov;38(11):1682-7.

PMID:
3185902
39.

Neuropsychological effects of antihypertensive drugs.

Wurzelmann J, Frishman WH, Aronson M, Masur D, Ooi WL.

Cardiol Clin. 1987 Nov;5(4):689-701.

PMID:
3454252
40.

AIDS in the workplace: Caveat employer.

Masur DA, Lynch MC.

Trends Tech Contemp Dent Lab. 1987 Oct;4(8):18, 20, 38. No abstract available.

PMID:
3478790
41.

Acute and chronic effects of oral physostigmine and lecithin in Alzheimer's disease.

Thal LJ, Masur DM, Sharpless NS, Fuld PA, Davies P.

Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):627-36.

PMID:
3797688
42.

Oral physostigmine and lecithin improve memory in Alzheimer disease.

Thal LJ, Fuld PA, Masur DM, Sharpless NS.

Ann Neurol. 1983 May;13(5):491-6.

PMID:
6347034
43.

Oral physostigmine and lecithin improve memory in Alzheimer's disease.

Thal LJ, Fuld PA, Masur DM, Sharpless NS, Davies P.

Psychopharmacol Bull. 1983;19(3):454-6. No abstract available.

PMID:
6635124

Supplemental Content

Support Center